Glutathione S-Transferase class μ deletion polymorphism and breast cancer: Results from prevalent versus incident cases

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 7, 1997, Pages 511-515

  Kelsey, Karl T ^a,b,c   Hankinson, Susan E ^a,c   Colditz, Graham A ^a,b,c   Springer, Kathryn ^a   Garcia Closas, Montserrat ^a   Spiegelman, Donna ^a   Manson, Joann E ^a,c   Garland, Miriam ^a,c   Stampfer, Meir J ^a,c   Willett, Walter C ^a,c   Speizer, Frank E ^a,c   Hunter, David J ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD CENTER FOR CANCER PREVENTION   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER INCIDENCE; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CHROMOSOME DELETION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROGNOSIS; UNITED STATES;

EID: 16944366994     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kelsey, J. L., and Horn-Ross, P. L. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol. Rev., 15: 7-16, 1993.
2. Colditz, G. A., and Frazier, A. L. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol. Biomarkers & Prev., 4: 567-571, 1995. ;
3. Madigan, M. P., Ziegler, R. G., Benichou, J., Byrne, C., and Hoover, R. N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J. Natl. Cancer Inst. (Bethesda), 87: 1681-1685, 1995.
4. Merzenich, H., Boeing, H., and Wahrendorf, J. Dietary fat and sports activity as determinants for age at menarche. Am. J. Epidemiol., 138: 217-224, 1993.
5. Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton-Culver, H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect., 101: 372-377, 1993.
6. Russo, J., and Russo, I. H. Biological and molecular basis of mammary carcinogenesis. Lab. Invest., 57: 112-137, 1987.
7. Yuspa, S. H., and Poirier, M. C. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv. Cancer Res., 50: 25-70, 1988.
8. Calaf, G., and Russo, J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis (Lond.), 14: 483-492, 1993.
9. 32P postlabeling analysis of DNA adducts in human and rat mammary epithelial cells. Carcinogenesis (Lond.), 9: 1071-1077, 1988.
10. 32P postlabeling analysis of DNA from human tissues. Mutat. Res., 282: 139-145, 1992.
11. Perera, F. P., Estabrook, A., Hewer, A., Channing, K., Rundle, A., Mooney, L., Wayatt, R., and Phillips, D. H. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol., Biomarkers & Prev., 4: 233-238, 1995.
12. Li, D., Wang, M., Dhingra, K., and Hittelman, W. N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res., 50: 287-293, 1996.
13. Ketterer, B., and Christodoulides, L. G. Enzymology of cytosolic glutathione S-transferase. Adv. Pharmacol., 27: 37-69, 1994.
14. Seidegard, J., and Pero, R. W. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum. Genet., 69: 66-68, 1985.
15. Wiencke, J. K., Kelsey, K. T., Lamela, R. A., and Toscano, W. Human glutathione-S-transferase deficiency: a marker of susceptibility to induced chromosome damage. Cancer Res., 50: 1585-1590, 1990.
16. McWilliams, J. E., Sanderson, B. J. S., Harris, E. L., Richert-Boe, K. E., and Henner, W. D. Glutathione 5-transferase MI (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol., Biomarkers & Prev., 4: 589-594, 1995.
17. Hirvonen, A. Genetic factors in individual responses to environmental exposures. J. Occ. Env. Med., 37: 37-43, 1995.
18. Zhong, S., Wyllie, A. H., Barnes, D., Wolf, C. R., and Spurr, N. K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (Lond.), 14: 1821-1824, 1993.
19. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A., Ford, T. D., and Shields, P. G. Cytochrome P4501A1 and glutalhione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55: 3483-3485, 1995.
20. Paradiso, A., Vetrugno, M. G., Capuano, G., Longo, S., Sibilano, L., Schittulli, F., Correale, M., Barletta, A., Pelagio, G., and De Lena, M. Expression of GST-μ transferase in breast cancer patients and healthy controls. Int. J. Biol. Markers, 9: 219-223, 1994.